US pharma major Eli Lilly plans to launch a new medication by the end of this year to enhance its diabetes treatment portfolio in India.

The company that sells a range of medicines and drug delivery devices in the diabetes segment is awaiting regulatory approval for the new p...

Olaizola, however, said the company is "working to ensure we comply with all orders issued by the NPPA regarding pricing of medicines."

Young CEOs tell aspirants how to hold a vision and see it through — whether it’s by giving themselves the freedom to make mistakes or stick...

The Indian arm of Eli Lilly is attempting new drug pricing models here to ensure that its drugs can reach a large number of patients.

The company lays maximum emphasis on its diabetes portfolio and would be introducing new products to cater to over 60 million patients in t...

Drug firm Eli Lilly and Company India today said it has entered into branded generics segment in the country with the launch of four cancer...